Araştırma Makalesi
BibTex RIS Kaynak Göster

Ağır Obstrüktif Uyku Apne Sendromlu Hastalarda Ortalama Trombosit Hacminin Değerlendirilmesi

Yıl 2015, Cilt: 12 Sayı: 2, 206 - 210, 30.08.2015

Öz

Amaç: Bu çalışmada ağır tıkayıcı uyku apne sendromlu (OSAS) hastalarda kan koagülabilitesiyle ilişkili
Ortalama Trombosit Hacmini (MPV) ve Plateletcriti (PCT) değerlendirmeyi amaçladık.
Gereç ve yöntemler: Uyku ünitesinde Eylül 2013 öncesi polisomnografi yapılan 98 hastanın kayıtları
retrospektif değerlendirildi. Tüm olgular apne-hipopne indeksine(AHİ) göre AHİ <5 / saat (s=48) AGrubu
(kontrol), AHİ ≥ 30 / saat ile B Grubu (s = 50) şeklinde gruplandırıldı. MPVve PCT(plateletcrit) otomatik bir
kan hücresi sayacı kullanılarak ölçüldü. Polisomnografik bulgularla, demografik ve kan parametreleri
karşılaştırıldı.
Bulgular: A ve B grupları arasında MPV (7.17±0.98 karşılık 7.54±1.21fL, p=0.66) ve PCT (0.218±0.06
karşılık 0.212±0.05, p=0.66) açısından anlamlı farklılık bulunamadı. Ağır OSAS grubunda MPV, PCT ile
AHİ parametreleri arasında anlamlı korelasyon saptanmadı(r=0.37, p=0.801 ve r=0.61, p=0.624).
Sonuç: MPV ve PCT değerlerinde ağır OSAS'lı hastalarda kontrole göre anlamlı yükseklik bulunmadı.Bu
bulgular yapılan ilk çalışmaların aksine MPV'nin OSAS'ın ağırlığıyla ilişkili bir parametre olmadığı ve
OSAS'ın doğrudan trombosit aktivitesini etkilemediğini düşündürmektedir.

Kaynakça

  • 1) Young T, Finn L, Peppard PE, et al. Sleep disordered breathing and mortality: Eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 2008;31(8):1071-8. 2) Wolk R, Kara T, Somers VK. Sleep-disordered breathing and cardiovascular disease. Circulation 2003;108(1):9-12. Review. 3) Minoguchi K, Yokoe T, Tazaki T, et al. Silent brain infarction and platelet activation in obstructive sleep apnea. Am J Respir Crit Care Med 2007;175(6):612-7. 4) Mehra R, Benjamin EJ, Shahar E, et al. Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med 2006;173(8):910-6. 5) Marin JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with orwithout treatment with continuous positive airway pressure: An observational study. Lancet 2005;365(9464):1046-53. 6) Shahar E, Whitney CW, Redline S, et al. Sleepdisordered breathing and cardiovascular disease. Crosssectional results of the sleep hearthealth study. Am J Respir Crit Care Med 2001;163:19-25. 7) Schulz R. The vascular micromilieu in obstructive sleep apnoea.Eur Respir J 2005;25(5):780-2. 8) Ryan S, Taylor CT, McNicholas WT, Ryan S, Taylor CT,McNicholas WT. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome.Circulation 2005;112(17):2660-7. 9) Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K,Chrousos GP. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 1997;82(5):1313-6. 10) Thompson CB, Eaton KA, Princiotta SM, Rushin CA, Valeri CR. Size dependent platelet subpopulations: relationship of platelet volume to ultrastructure, enzymatic activity, and function. Br J Haematol 1982;50(3):509-19. 11)Briggs C. Quality counts: new parameters in blood cell counting. Int J Lab Hematol 2009;31(3):277-97. Review. 12) Vizioli L, Muscari S, Muscari A, “The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases,” Int J Clin Pract, 2009;63(10):1509-15. 13) Korkmaz L, Korkmaz AA, Akyüz AR, et al., Association between mean platelet volume and coronary artery calcification in patients without overt cardiovascular disease: an observational study. Anadolu Kardiyoloji Dergisi, 2012;(12)1: 35–9,. 14) Geiser T, Buck F, Meyer BJ, et al. In vivo platelet activation is increased during sleep in patients with obstructive sleep apnea syndrome. Respiration 2002;69(3):229-34. 15) Hui DS, Ko FW, Fok JP, et al. The effects of nasal continuous positive airway pressure on platelet acti¬vation in obstructive sleep apnea syndrome. Chest 2004;125(5):1768-75. 16) Erden EŞ, Yengil E, Tuncel E, Bilgiç HK, Demirköse M, Motor S, Genç S. Investigation of the relationship between mean platelet volume and obstructive sleep apnea syndrome J Clin Exp Invest 2013;4(4):492-6. 17) Varol E, Ozturk O, Gonca T, et all. Mean platelet volume is increased in patients with severe obstructive sleep apnea. Scand J Clin Lab Invest 2010;70(7):497-502. 18) Kanbay A, Tutar N, Kaya E, et al. Mean platelet volume in patients with obstructive sleep apnea syn¬drome and its relationship with cardiovascular diseases. Blood Coagul Fibrinolysis 2013;24(5):532-6. 19) Nena E, Papanas N, Steiropoulos P, et al. Mean Platelet Volume and Platelet Distribution Width in non-diabetic subjects with obstructive sleep apnoea syndrome: new indices of severity? Platelets 2012;23(6):447-54. 20) Sökücü SN, Özdemir C, Dalar L, Karasulu L, Aydın F, Altın S. Is Mean Platelet Volume Really a Severity Marker for Obstructive Sleep Apnea Syndrome without Comorbidities? Pulm Med. 2014;2014:754839 21) Rahangdale S, Yeh SY, Novack V et all. “The influence of intermittent hypoxemia on platelet activation in obese patients with obstructive sleep apnea,” J Clin Sleep Med. 2011;7(2):172-8.

Assessment Of Mean Platelet Volume In Patients With Severe Obstructive Sleep Apnea

Yıl 2015, Cilt: 12 Sayı: 2, 206 - 210, 30.08.2015

Öz

Objective: In this study we aimed to evaluate the mean platelet volume (MPV) and Plateletcrit (PCT)
associated with blood coagulability in patients with severe obstructive sleep apnea syndrome (OSAS).
Materials And Methods: The polysomnography recordings of 98 patients admitted to the sleep laboratory
before September 2013 were retrospectively evaluated. All cases were grouped according to their AHI value
as AHI <5 / h (n = 48) Group A (control) and AHI ≥ 30 / hour and Group B (n = 50). MPV and PCT
(plateletcrit) was measured using an automatic blood cell counter. Polysomnographic findings, demographic
data and blood parameters were compared. Results: No significant differences were found between Aand B groups with respect to PCT (0.218±0.06 vs.
0.212±0.05, p=0.66) and MPV (7.17±0.98 vs. 7.54±1.21fL, p=0.66). In severe OSAS group, MPV and PCT
werenot correlated with AHİ (r=0.37, p=0.801 and r=0.61, p=0.624).
Conclusion: MPV and PCT levels werenot higher in severe OSAS group compared to the control group.
Unlike previous studies, these findings suggest that MPV isnot associated with the severity of OSAS and
OSAS does not directly affect the platelet activity

Kaynakça

  • 1) Young T, Finn L, Peppard PE, et al. Sleep disordered breathing and mortality: Eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 2008;31(8):1071-8. 2) Wolk R, Kara T, Somers VK. Sleep-disordered breathing and cardiovascular disease. Circulation 2003;108(1):9-12. Review. 3) Minoguchi K, Yokoe T, Tazaki T, et al. Silent brain infarction and platelet activation in obstructive sleep apnea. Am J Respir Crit Care Med 2007;175(6):612-7. 4) Mehra R, Benjamin EJ, Shahar E, et al. Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med 2006;173(8):910-6. 5) Marin JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with orwithout treatment with continuous positive airway pressure: An observational study. Lancet 2005;365(9464):1046-53. 6) Shahar E, Whitney CW, Redline S, et al. Sleepdisordered breathing and cardiovascular disease. Crosssectional results of the sleep hearthealth study. Am J Respir Crit Care Med 2001;163:19-25. 7) Schulz R. The vascular micromilieu in obstructive sleep apnoea.Eur Respir J 2005;25(5):780-2. 8) Ryan S, Taylor CT, McNicholas WT, Ryan S, Taylor CT,McNicholas WT. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome.Circulation 2005;112(17):2660-7. 9) Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K,Chrousos GP. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 1997;82(5):1313-6. 10) Thompson CB, Eaton KA, Princiotta SM, Rushin CA, Valeri CR. Size dependent platelet subpopulations: relationship of platelet volume to ultrastructure, enzymatic activity, and function. Br J Haematol 1982;50(3):509-19. 11)Briggs C. Quality counts: new parameters in blood cell counting. Int J Lab Hematol 2009;31(3):277-97. Review. 12) Vizioli L, Muscari S, Muscari A, “The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases,” Int J Clin Pract, 2009;63(10):1509-15. 13) Korkmaz L, Korkmaz AA, Akyüz AR, et al., Association between mean platelet volume and coronary artery calcification in patients without overt cardiovascular disease: an observational study. Anadolu Kardiyoloji Dergisi, 2012;(12)1: 35–9,. 14) Geiser T, Buck F, Meyer BJ, et al. In vivo platelet activation is increased during sleep in patients with obstructive sleep apnea syndrome. Respiration 2002;69(3):229-34. 15) Hui DS, Ko FW, Fok JP, et al. The effects of nasal continuous positive airway pressure on platelet acti¬vation in obstructive sleep apnea syndrome. Chest 2004;125(5):1768-75. 16) Erden EŞ, Yengil E, Tuncel E, Bilgiç HK, Demirköse M, Motor S, Genç S. Investigation of the relationship between mean platelet volume and obstructive sleep apnea syndrome J Clin Exp Invest 2013;4(4):492-6. 17) Varol E, Ozturk O, Gonca T, et all. Mean platelet volume is increased in patients with severe obstructive sleep apnea. Scand J Clin Lab Invest 2010;70(7):497-502. 18) Kanbay A, Tutar N, Kaya E, et al. Mean platelet volume in patients with obstructive sleep apnea syn¬drome and its relationship with cardiovascular diseases. Blood Coagul Fibrinolysis 2013;24(5):532-6. 19) Nena E, Papanas N, Steiropoulos P, et al. Mean Platelet Volume and Platelet Distribution Width in non-diabetic subjects with obstructive sleep apnoea syndrome: new indices of severity? Platelets 2012;23(6):447-54. 20) Sökücü SN, Özdemir C, Dalar L, Karasulu L, Aydın F, Altın S. Is Mean Platelet Volume Really a Severity Marker for Obstructive Sleep Apnea Syndrome without Comorbidities? Pulm Med. 2014;2014:754839 21) Rahangdale S, Yeh SY, Novack V et all. “The influence of intermittent hypoxemia on platelet activation in obese patients with obstructive sleep apnea,” J Clin Sleep Med. 2011;7(2):172-8.
Toplam 1 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Bölüm Araştırma Makalesi
Yazarlar

Zafer Hasan Ali Sak

Funda Yalçın Bu kişi benim

Ayşegül Öney Kurnaz Bu kişi benim

Mehmet Gencer Bu kişi benim

İrfan Eser Bu kişi benim

Şamil Günay Bu kişi benim

Yayımlanma Tarihi 30 Ağustos 2015
Gönderilme Tarihi 29 Ocak 2015
Kabul Tarihi 3 Şubat 2015
Yayımlandığı Sayı Yıl 2015 Cilt: 12 Sayı: 2

Kaynak Göster

Vancouver Sak ZHA, Yalçın F, Kurnaz AÖ, Gencer M, Eser İ, Günay Ş. Ağır Obstrüktif Uyku Apne Sendromlu Hastalarda Ortalama Trombosit Hacminin Değerlendirilmesi. Harran Üniversitesi Tıp Fakültesi Dergisi. 2015;12(2):206-10.

Harran Üniversitesi Tıp Fakültesi Dergisi  / Journal of Harran University Medical Faculty